CLINICAL_TRIALS
research
· 2011-06-13
Clinical Trial Update: Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
Summary
The document describes a clinical trial exploring whether serum IGF-II can be used to monitor and screen for cervical cancer. It lists Onconix, Inc. as sponsor …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Onconix, Inc | Conditions: Cervical Cancer, Cervical Intraepithelial Neoplasia II | Status: UNKNOWN